Title : A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan &\; Ciclosporin in COLOrectal cancer therapy trial (PICCOLO) - Middleton_2013_Eur.J.Cancer_49_3507 |
Author(s) : Middleton G , Brown S , Lowe C , Maughan T , Gwyther S , Oliver A , Richman S , Blake D , Napp V , Marshall H , Wadsley J , Maisey N , Chau I , Hill M , Gollins S , Myint S , Slater S , Wagstaff J , Bridgewater J , Seymour M |
Ref : Eur J Cancer , 49 :3507 , 2013 |
Abstract : Middleton_2013_Eur.J.Cancer_49_3507 |
ESTHER : Middleton_2013_Eur.J.Cancer_49_3507 |
PubMedSearch : Middleton_2013_Eur.J.Cancer_49_3507 |
PubMedID: 23953030 |
Middleton G, Brown S, Lowe C, Maughan T, Gwyther S, Oliver A, Richman S, Blake D, Napp V, Marshall H, Wadsley J, Maisey N, Chau I, Hill M, Gollins S, Myint S, Slater S, Wagstaff J, Bridgewater J, Seymour M (2013)
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan &\; Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
Eur J Cancer
49 :3507
Middleton G, Brown S, Lowe C, Maughan T, Gwyther S, Oliver A, Richman S, Blake D, Napp V, Marshall H, Wadsley J, Maisey N, Chau I, Hill M, Gollins S, Myint S, Slater S, Wagstaff J, Bridgewater J, Seymour M (2013)
Eur J Cancer
49 :3507